{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T02:12:55Z","timestamp":1768529575258,"version":"3.49.0"},"reference-count":152,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.thromres.2013.11.007","type":"journal-article","created":{"date-parts":[[2013,11,16]],"date-time":"2013-11-16T13:15:22Z","timestamp":1384607722000},"page":"308-314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Role of multiligand\/RAGE axis in platelet activation"],"prefix":"10.1016","volume":"133","author":[{"given":"Eduardo","family":"Fuentes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iv\u00e1n","family":"Palomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2013.11.007_bb0005","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacc.2012.11.002","article-title":"The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology","volume":"60","author":"Laslett","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0010","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1161\/CIRCULATIONAHA.108.846519","article-title":"Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study","volume":"120","author":"Preis","year":"2009","journal-title":"Circulation"},{"issue":"Suppl. 2","key":"10.1016\/j.thromres.2013.11.007_bb0015","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.2337\/dc08-s257","article-title":"Cardiovascular complications in diabetes: targets and interventions","volume":"31","author":"Stirban","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.thromres.2013.11.007_bb0020","doi-asserted-by":"crossref","first-page":"136584","DOI":"10.1155\/2013\/136584","article-title":"Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndrome","volume":"2013","author":"Fuentes","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.thromres.2013.11.007_bb0025","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0735-1097(01)01555-8","article-title":"Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control","volume":"38","author":"Osende","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0030","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.thromres.2013.11.007_bb0035","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/1479164112460253","article-title":"Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients","volume":"10","author":"Kerkeni","year":"2013","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.thromres.2013.11.007_bb0040","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/157016108783331312","article-title":"Advanced Glycation and ROS: a link between diabetes and heart failure","volume":"6","author":"Rojas","year":"2008","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0045","doi-asserted-by":"crossref","first-page":"10197","DOI":"10.1016\/S0021-9258(17)34043-7","article-title":"Macrophages adhere to glucose-modified basement membrane collagen IV via their scavenger receptors","volume":"269","author":"el Khoury","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2013.11.007_bb0050","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/BF03401604","article-title":"Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex","volume":"1","author":"Vlassara","year":"1995","journal-title":"Mol Med"},{"key":"10.1016\/j.thromres.2013.11.007_bb0055","doi-asserted-by":"crossref","first-page":"11047","DOI":"10.1073\/pnas.93.20.11047","article-title":"Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80 K-H membrane proteins","volume":"93","author":"Li","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.thromres.2013.11.007_bb0060","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1056-8727(01)00208-2","article-title":"CD36, serves as a receptor for advanced glycation endproducts (AGE)","volume":"16","author":"Ohgami","year":"2002","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.thromres.2013.11.007_bb0065","first-page":"1699","article-title":"Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues","volume":"143","author":"Brett","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0070","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2004.09.059","article-title":"Splice variants of the receptor for advanced glycosylation end products (RAGE) in human brain","volume":"373","author":"Ding","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.thromres.2013.11.007_bb0075","doi-asserted-by":"crossref","first-page":"14998","DOI":"10.1016\/S0021-9258(18)42138-2","article-title":"Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins","volume":"267","author":"Neeper","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2013.11.007_bb0080","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1677\/JOE-06-0081","article-title":"Advanced glycation endproducts mediate pro-inflammatory actions in human gestational tissues via nuclear factor-kappaB and extracellular signal-regulated kinase 1\/2","volume":"193","author":"Lappas","year":"2007","journal-title":"J Endocrinol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0085","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cardiores.2004.05.001","article-title":"Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes","volume":"63","author":"Basta","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.thromres.2013.11.007_bb0090","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.atherosclerosis.2012.10.050","article-title":"Role of endogenous secretory RAGE (esRAGE) in defending against plaque formation induced by oxidative stress in type 2 diabetic patients","volume":"226","author":"Piarulli","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.thromres.2013.11.007_bb0095","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.tcm.2005.08.003","article-title":"The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond","volume":"15","author":"Ramasamy","year":"2005","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.thromres.2013.11.007_bb0100","doi-asserted-by":"crossref","first-page":"40762","DOI":"10.1074\/jbc.M110.169276","article-title":"The 1.5 A crystal structure of human receptor for advanced glycation endproducts (RAGE) ectodomains reveals unique features determining ligand binding","volume":"285","author":"Park","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2013.11.007_bb0105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/cvr\/cvn163","article-title":"High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice","volume":"80","author":"Kitahara","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.thromres.2013.11.007_bb0110","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1084\/jem.20012044","article-title":"A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation","volume":"196","author":"Massberg","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.thromres.2013.11.007_bb0115","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00394-009-0038-6","article-title":"Advanced glycation end products strongly activate platelets","volume":"48","author":"Gawlowski","year":"2009","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.thromres.2013.11.007_bb0120","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1158\/1055-9965.EPI-11-0066","article-title":"Advanced glycation end products, soluble receptor for advanced glycation end products, and risk of colorectal cancer","volume":"20","author":"Jiao","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.thromres.2013.11.007_bb0125","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2337\/diacare.22.9.1543","article-title":"Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease","volume":"22","author":"Kilhovd","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.thromres.2013.11.007_bb0130","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0002-9440(10)65659-3","article-title":"Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases","volume":"153","author":"Sasaki","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0135","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/jcla.20455","article-title":"High levels of hsCRP are associated with carbohydrate metabolism disorder","volume":"25","author":"Leiva","year":"2011","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.thromres.2013.11.007_bb0140","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.str.2011.02.013","article-title":"Advanced glycation end product recognition by the receptor for AGEs","volume":"19","author":"Xue","year":"2011","journal-title":"Structure"},{"key":"10.1016\/j.thromres.2013.11.007_bb0145","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","article-title":"Advanced glycation end products: sparking the development of diabetic vascular injury","volume":"114","author":"Goldin","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2013.11.007_bb0150","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/psc.573","article-title":"Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease","volume":"10","author":"Verdier","year":"2004","journal-title":"J Pept Sci"},{"key":"10.1016\/j.thromres.2013.11.007_bb0155","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/76216","article-title":"Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis","volume":"6","author":"Yan","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.thromres.2013.11.007_bb0160","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0092-8674(00)80801-6","article-title":"RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100\/calgranulin polypeptides","volume":"97","author":"Hofmann","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.thromres.2013.11.007_bb0165","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1084\/jem.20030800","article-title":"The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment","volume":"198","author":"Chavakis","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.thromres.2013.11.007_bb0170","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1055\/s-0031-1283161","article-title":"Relationship of soluble RAGE and RAGE ligands HMGB1 and EN-RAGE to endothelial dysfunction in type 1 and type 2 diabetes mellitus","volume":"120","author":"Skrha","year":"2012","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.thromres.2013.11.007_bb0175","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1161\/ATVBAHA.107.143479","article-title":"Activation of human platelets by misfolded proteins","volume":"27","author":"Herczenik","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0180","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1161\/STROKEAHA.111.642256","article-title":"High levels of S100A12 are associated with recent plaque symptomatology in patients with carotid atherosclerosis","volume":"43","author":"Abbas","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2013.11.007_bb0185","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/ATVBAHA.110.217745","article-title":"S100A12 in vascular smooth muscle accelerates vascular calcification in apolipoprotein E-null mice by activating an osteogenic gene regulatory program","volume":"31","author":"Hofmann Bowman","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0190","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1055\/s-0030-1251503","article-title":"The role of HMGB1\/RAGE in inflammatory cardiomyopathy","volume":"36","author":"Volz","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2013.11.007_bb0195","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1161\/CIRCULATIONAHA.108.769331","article-title":"High-mobility group box-1 in ischemia-reperfusion injury of the heart","volume":"117","author":"Andrassy","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2013.11.007_bb0200","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/01.ATV.0000131783.74034.97","article-title":"Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study","volume":"24","author":"Burke","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0205","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cellsig.2012.11.022","article-title":"The receptor for advanced glycation end-products: a complex signaling scenario for a promiscuous receptor","volume":"25","author":"Rojas","year":"2013","journal-title":"Cell Signal"},{"key":"10.1016\/j.thromres.2013.11.007_bb0210","doi-asserted-by":"crossref","first-page":"e1001315","DOI":"10.1371\/journal.ppat.1001315","article-title":"The danger signal S100B integrates pathogen- and danger-sensing pathways to restrain inflammation","volume":"7","author":"Sorci","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.thromres.2013.11.007_bb0215","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/carcin\/bgp322","article-title":"Fueling inflammation at tumor microenvironment: the role of multiligand\/RAGE axis","volume":"31","author":"Rojas","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.thromres.2013.11.007_bb0220","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/intimm\/dxr083","article-title":"Human eosinophils express RAGE, produce RAGE ligands, exhibit PKC-delta phosphorylation and enhanced viability in response to the RAGE ligand, S100B","volume":"23","author":"Curran","year":"2011","journal-title":"Int Immunol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0225","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1161\/01.CIR.0000086014.80477.0D","article-title":"The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control","volume":"108","author":"Cipollone","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2013.11.007_bb0230","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jep.2013.03.035","article-title":"Protection of glycyrrhizic acid against AGEs-induced endothelial dysfunction through inhibiting RAGE\/NF-kappaB pathway activation in human umbilical vein endothelial cells","volume":"148","author":"Feng","year":"2013","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0235","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/jcp.22492","article-title":"Involvement of membrane type 1-matrix metalloproteinase (MT1-MMP) in RAGE activation signaling pathways","volume":"226","author":"Kamioka","year":"2011","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0240","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1161\/01.ATV.0000133191.71196.90","article-title":"RAGE axis: Animal models and novel insights into the vascular complications of diabetes","volume":"24","author":"Naka","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0245","doi-asserted-by":"crossref","first-page":"E1726","DOI":"10.1210\/jc.2012-1473","article-title":"Endogenous secretory RAGE in obese women: association with platelet activation and oxidative stress","volume":"97","author":"Vazzana","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.thromres.2013.11.007_bb0250","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.1182\/blood-2009-01-201970","article-title":"Vav guanine nucleotide exchange factors link hyperlipidemia and a prothrombotic state","volume":"117","author":"Chen","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.11.007_bb0255","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.blre.2009.04.001","article-title":"Platelet alpha-granules: basic biology and clinical correlates","volume":"23","author":"Blair","year":"2009","journal-title":"Blood Rev"},{"key":"10.1016\/j.thromres.2013.11.007_bb0260","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/j.1537-2995.2006.00869.x","article-title":"Release of potential immunomodulatory factors during platelet storage","volume":"46","author":"Cognasse","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.thromres.2013.11.007_bb0265","doi-asserted-by":"crossref","first-page":"8120","DOI":"10.3390\/molecules18078120","article-title":"Protective mechanisms of guanosine from Solanum lycopersicum on agonist-induced platelet activation: role of sCD40L","volume":"18","author":"Fuentes","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.thromres.2013.11.007_bb0270","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1189\/jlb.0605318","article-title":"Platelet binding to monocytes increases the adhesive properties of monocytes by up-regulating the expression and functionality of beta1 and beta2 integrins","volume":"79","author":"da Costa Martins","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0275","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1161\/01.ATV.0000106320.40933.E5","article-title":"Platelet-monocyte complexes support monocyte adhesion to endothelium by enhancing secondary tethering and cluster formation","volume":"24","author":"da Costa Martins","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0280","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/09537104.2012.690113","article-title":"Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis","volume":"24","author":"Fuentes","year":"2013","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2013.11.007_bb0285","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/09537100902795492","article-title":"Glycated albumin modulates platelet susceptibility to flow induced activation and aggregation","volume":"20","author":"Rubenstein","year":"2009","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2013.11.007_bb0290","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.amjcard.2003.08.033","article-title":"Effects of increased concentrations of glucose on platelet reactivity in healthy subjects and in patients with and without diabetes mellitus","volume":"92","author":"Keating","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0295","doi-asserted-by":"crossref","first-page":"26B","DOI":"10.1016\/0002-9149(93)90142-Y","article-title":"Glycation and oxidation: a role in the pathogenesis of atherosclerosis","volume":"71","author":"Lyons","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0300","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/S0891-5849(00)00228-8","article-title":"Glycoxidation and lipoxidation in atherogenesis","volume":"28","author":"Baynes","year":"2000","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.thromres.2013.11.007_bb0305","first-page":"654","article-title":"Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody","volume":"147","author":"Kume","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0310","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1161\/CIRCULATIONAHA.109.913376","article-title":"Diabetes and antiplatelet therapy in acute coronary syndrome","volume":"123","author":"Ferreiro","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2013.11.007_bb0315","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0049-3848(02)00348-1","article-title":"Enhancing effect of advanced glycation end products on serotonin-induced platelet aggregation in patients with diabetes mellitus","volume":"107","author":"Hasegawa","year":"2002","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2013.11.007_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8227(00)00160-1","article-title":"The role of platelets in diabetes-related vascular complications","volume":"50","author":"Sobol","year":"2000","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.thromres.2013.11.007_bb0325","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2741\/s57","article-title":"Pathophysiology of the proatherothrombotic state in the metabolic syndrome","volume":"2","author":"Palomo","year":"2010","journal-title":"Front Biosci (Schol Ed)"},{"key":"10.1016\/j.thromres.2013.11.007_bb0330","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/bbrc.1998.8945","article-title":"Increased aggregation of human platelets produced by advanced glycation end products in vitro","volume":"248","author":"Hangaishi","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.thromres.2013.11.007_bb0335","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1440-1681.2007.04680.x","article-title":"17Beta-oestradiol partially attenuates the inhibition of nitric oxide synthase-3 by advanced glycation end-products in human platelets","volume":"34","author":"Chen","year":"2007","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0340","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1024\/0300-9831\/a000019","article-title":"Pyridoxine improves platelet nitric oxide synthase dysfunction induced by advanced glycation end products in vitro","volume":"80","author":"Han","year":"2010","journal-title":"Int J Vitam Nutr Res"},{"key":"10.1016\/j.thromres.2013.11.007_bb0345","doi-asserted-by":"crossref","first-page":"E50","DOI":"10.1161\/01.RES.86.3.e50","article-title":"Regulation of endothelial nitric oxide synthase expression by albumin-derived advanced glycosylation end products","volume":"86","author":"Rojas","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.thromres.2013.11.007_bb0350","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/157340810790712050","article-title":"Modulation of Nitric Oxide Pathway by Multiligands\/RAGE Axis: A Crossing Point on the Road to Microvascular Complication in Diabetes","volume":"6","author":"Rojas","year":"2010","journal-title":"Curr Enzyme Inhib"},{"key":"10.1016\/j.thromres.2013.11.007_bb0355","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1007\/s00018-005-5099-y","article-title":"Activated scramblase and inhibited aminophospholipid translocase cause phosphatidylserine exposure in a distinct platelet fraction","volume":"62","author":"Wolfs","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.thromres.2013.11.007_bb0360","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.2337\/diacare.24.11.2001-a","article-title":"Increased platelet and erythrocyte external cell membrane phosphatidylserine in type 1 diabetes and microalbuminuria","volume":"24","author":"Wahid","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.thromres.2013.11.007_bb0365","doi-asserted-by":"crossref","first-page":"C328","DOI":"10.1152\/ajpcell.00560.2006","article-title":"Advanced glycation end products elicit externalization of phosphatidylserine in a subpopulation of platelets via 5-HT2A\/2C receptors","volume":"293","author":"Wang","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0370","first-page":"1934","article-title":"Platelet CD36 mediates interactions with endothelial cell-derived microparticles and contributes to thrombosis in mice","volume":"118","author":"Ghosh","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.thromres.2013.11.007_bb0375","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/nm1626","article-title":"Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype","volume":"13","author":"Podrez","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.thromres.2013.11.007_bb0380","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1749-6632.2001.tb03961.x","article-title":"CD36, a member of class B scavenger receptor family, is a receptor for advanced glycation end products","volume":"947","author":"Ohgami","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.thromres.2013.11.007_bb0385","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1182\/blood-2011-10-387506","article-title":"Advanced glycation end products induce a prothrombotic phenotype in mice via interaction with platelet CD36","volume":"119","author":"Zhu","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.11.007_bb0390","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1074\/jbc.M006545200","article-title":"Cd36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products","volume":"276","author":"Ohgami","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2013.11.007_bb0395","doi-asserted-by":"crossref","first-page":"40817","DOI":"10.1074\/jbc.M112.398578","article-title":"Soluble amyloid precursor protein 770 is released from inflamed endothelial cells and activated platelets: a novel biomarker for acute coronary syndrome","volume":"287","author":"Kitazume","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2013.11.007_bb0400","doi-asserted-by":"crossref","first-page":"17036","DOI":"10.1074\/jbc.M006285200","article-title":"Amyloid precursor protein and amyloid beta peptide in human platelets Role of cyclooxygenase and protein kinase C","volume":"276","author":"Skovronsky","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2013.11.007_bb0405","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1196\/annals.1397.082","article-title":"Release of beta-amyloid from high-density platelets: implications for Alzheimer's disease pathology","volume":"1096","author":"Casoli","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.thromres.2013.11.007_bb0410","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.lfs.2004.09.011","article-title":"Advanced glycation and endothelial functions: a link towards vascular complications in diabetes","volume":"76","author":"Rojas","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.thromres.2013.11.007_bb0415","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1089\/ars.2007.1999","article-title":"Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway","volume":"10","author":"Guo","year":"2008","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.thromres.2013.11.007_bb0420","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1210\/en.2010-0323","article-title":"Involvement of RAGE, NADPH oxidase, and Ras\/Raf-1 pathway in glycated LDL-induced expression of heat shock factor-1 and plasminogen activator inhibitor-1 in vascular endothelial cells","volume":"151","author":"Sangle","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.thromres.2013.11.007_bb0425","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00418-004-0672-2","article-title":"Regulation of the NADPH-oxidase complex of phagocytic leukocytes. Recent insights from structural biology, molecular genetics, and microscopy","volume":"122","author":"Robinson","year":"2004","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0430","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0049-3848(01)00341-3","article-title":"Involvement of NADH\/NADPH oxidase in human platelet ROS production","volume":"103","author":"Seno","year":"2001","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2013.11.007_bb0435","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1089\/1523086041361640","article-title":"Functional role of NADPH oxidase in activation of platelets","volume":"6","author":"Chlopicki","year":"2004","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.thromres.2013.11.007_bb0440","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1182\/blood-2005-03-1047","article-title":"Platelet NAD(P)H-oxidase-generated ROS production regulates alphaIIbbeta3-integrin activation independent of the NO\/cGMP pathway","volume":"106","author":"Begonja","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.11.007_bb0445","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1530\/EJE-10-0904","article-title":"Receptor for advanced glycation end-products expression in subcutaneous adipose tissue is related to coronary artery disease","volume":"164","author":"Rodino-Janeiro","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0450","doi-asserted-by":"crossref","first-page":"e66781","DOI":"10.1371\/journal.pone.0066781","article-title":"Advanced glycation end products induce human corneal epithelial cells apoptosis through generation of reactive oxygen species and activation of JNK and p38 MAPK pathways","volume":"8","author":"Shi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2013.11.007_bb0455","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2261-13-13","article-title":"Advanced glycation end products accelerate rat vascular calcification through RAGE\/oxidative stress","volume":"13","author":"Wei","year":"2013","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.thromres.2013.11.007_bb0460","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11010-011-1114-9","article-title":"Advanced glycation end products enhance reactive oxygen and nitrogen species generation in neutrophils in vitro","volume":"361","author":"Bansal","year":"2012","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.thromres.2013.11.007_bb0465","first-page":"00743-1","article-title":"Advanced glycation end products as an upstream molecule triggers ROS-induced sFlt-1 production in extravillous trophoblasts: A novel bridge between oxidative stress and preeclampsia","volume":"S0143\u20134004","author":"Huang","year":"2013","journal-title":"Placenta"},{"key":"10.1016\/j.thromres.2013.11.007_bb0470","doi-asserted-by":"crossref","first-page":"e11093","DOI":"10.1371\/journal.pone.0011093","article-title":"Precursor of advanced glycation end products mediates ER-stress-induced caspase-3 activation of human dermal fibroblasts through NAD(P)H oxidase 4","volume":"5","author":"Loughlin","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2013.11.007_bb0475","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1189\/jlb.0406262","article-title":"Activation of RAGE induces elevated O2- generation by mononuclear phagocytes in diabetes","volume":"81","author":"Ding","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0480","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1476-5381.2010.00905.x","article-title":"Advanced glycation end products (AGEs) activate mast cells","volume":"161","author":"Sick","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0485","doi-asserted-by":"crossref","first-page":"e34698","DOI":"10.1371\/journal.pone.0034698","article-title":"RAGE expression in human T cells: a link between environmental factors and adaptive immune responses","volume":"7","author":"Akirav","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2013.11.007_bb0490","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fitote.2013.01.014","article-title":"Catalpol suppresses advanced glycation end-products-induced inflammatory responses through inhibition of reactive oxygen species in human monocytic THP-1 cells","volume":"86","author":"Choi","year":"2013","journal-title":"Fitoterapia"},{"key":"10.1016\/j.thromres.2013.11.007_bb0495","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2337\/diabetes.50.6.1495","article-title":"Requirement for p38 and p44\/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion","volume":"50","author":"Yeh","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.thromres.2013.11.007_bb0500","doi-asserted-by":"crossref","first-page":"38635","DOI":"10.1074\/jbc.M202515200","article-title":"Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation","volume":"277","author":"Huttunen","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2013.11.007_bb0505","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/1097-4644(20010401)81:1<102::AID-JCB1027>3.0.CO;2-Y","article-title":"Role of receptor for advanced glycation end-product (RAGE) and the JAK\/STAT-signaling pathway in AGE-induced collagen production in NRK-49 F cells","volume":"81","author":"Huang","year":"2001","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.thromres.2013.11.007_bb0510","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.bcp.2010.01.013","article-title":"Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging","volume":"79","author":"Yan","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0515","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.2337\/diabetes.50.12.2792","article-title":"Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB","volume":"50","author":"Bierhaus","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.thromres.2013.11.007_bb0520","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood-2004-03-0926","article-title":"Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes","volume":"104","author":"Akbiyik","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.11.007_bb0530","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1096\/fj.05-4395fje","article-title":"Role of nuclear receptor signaling in platelets: antithrombotic effects of PPARbeta","volume":"20","author":"Ali","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.thromres.2013.11.007_bb0535","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1182\/blood-2005-04-1723","article-title":"Ligand-specific glucocorticoid receptor activation in human platelets","volume":"106","author":"Moraes","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.11.007_bb0540","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1182\/blood-2003-11-3840","article-title":"Nongenomic effects of 17beta-estradiol in human platelets: potentiation of thrombin-induced aggregation through estrogen receptor beta and Src kinase","volume":"105","author":"Moro","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.11.007_bb0545","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1182\/blood-2006-05-022566","article-title":"Nongenomic signaling of the retinoid X receptor through binding and inhibiting Gq in human platelets","volume":"109","author":"Moraes","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.11.007_bb0550","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1538-7836.2009.03492.x","article-title":"NF-kappaB inhibitors impair platelet activation responses","volume":"7","author":"Malaver","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.11.007_bb0555","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.steroids.2009.09.005","article-title":"The platelet as a model system for the acute actions of nuclear receptors","volume":"75","author":"Bishop-Bailey","year":"2010","journal-title":"Steroids"},{"key":"10.1016\/j.thromres.2013.11.007_bb0560","article-title":"Mechanisms of antiplatelet activity of nifedipine: role of peroxisome proliferator-activated receptor-beta-gamma-dependent processes","author":"Shih","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.thromres.2013.11.007_bb0565","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0049-3848(02)00130-5","article-title":"Demonstration of an activation regulated NF-kappaB\/I-kappaBalpha complex in human platelets","volume":"106","author":"Liu","year":"2002","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2013.11.007_bb0570","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1182\/blood-2006-10-051664","article-title":"Structure-function analysis reveals discrete beta3 integrin inside-out and outside-in signaling pathways in platelets","volume":"109","author":"Zou","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.11.007_bb0575","first-page":"2407","article-title":"Platelet activation leads to increased c-src kinase activity and association of c-src with an 85-kDa tyrosine phosphoprotein","volume":"7","author":"Wong","year":"1992","journal-title":"Oncogene"},{"key":"10.1016\/j.thromres.2013.11.007_bb0580","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1182\/blood.V95.3.959.003k22_959_964","article-title":"Activation of the small GTPases, rac and cdc42, after ligation of the platelet PAR-1 receptor","volume":"95","author":"Azim","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.11.007_bb0585","doi-asserted-by":"crossref","first-page":"27395","DOI":"10.1074\/jbc.270.46.27395","article-title":"Thrombin induces activation of p38 MAP kinase in human platelets","volume":"270","author":"Kramer","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2013.11.007_bb0590","first-page":"60","article-title":"Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease","volume":"1","author":"Badimon","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.thromres.2013.11.007_bb0595","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1182\/blood-2007-06-097410","article-title":"Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles","volume":"111","author":"Sprague","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.11.007_bb0600","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1084\/jem.187.3.329","article-title":"Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha","volume":"187","author":"Bombeli","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.thromres.2013.11.007_bb0605","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1182\/blood-2002-07-2209","article-title":"Platelet P-selectin facilitates atherosclerotic lesion development","volume":"101","author":"Burger","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.11.007_bb0610","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.jacc.2004.12.071","article-title":"Platelet P-selectin plays an important role in arterial thrombogenesis by forming large stable platelet-leukocyte aggregates","volume":"45","author":"Yokoyama","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0615","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1172\/JCI27209.","article-title":"Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling","volume":"116","author":"Dixon","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.thromres.2013.11.007_bb0620","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/ni1491","article-title":"P-selectin primes leukocyte integrin activation during inflammation","volume":"8","author":"Wang","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0625","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.thromres.2007.03.002","article-title":"AGEs and methylglyoxal induce apoptosis and expression of Mac-1 on neutrophils resulting in platelet-neutrophil aggregation","volume":"121","author":"Gawlowski","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2013.11.007_bb0630","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1182\/blood-2009-09-244293","article-title":"RAGE and ICAM-1 cooperate in mediating leukocyte recruitment during acute inflammation in vivo","volume":"116","author":"Frommhold","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.11.007_bb0635","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.1073\/pnas.92.16.7450","article-title":"Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin","volume":"92","author":"Frenette","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.thromres.2013.11.007_bb0640","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2172-12-56","article-title":"RAGE and ICAM-1 differentially control leukocyte recruitment during acute inflammation in a stimulus-dependent manner","volume":"12","author":"Frommhold","year":"2011","journal-title":"BMC Immunol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0645","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1073\/pnas.92.10.4342","article-title":"CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression","volume":"92","author":"Karmann","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.thromres.2013.11.007_bb0650","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/35393","article-title":"CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells","volume":"391","author":"Henn","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.thromres.2013.11.007_bb0655","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jlb.63.3.373","article-title":"CD40L-CD40 interactions regulate endothelial cell surface tissue factor and thrombomodulin expression","volume":"63","author":"Miller","year":"1998","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0660","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1055\/s-0037-1614175","article-title":"Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation","volume":"84","author":"Rouhiainen","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.11.007_bb0665","doi-asserted-by":"crossref","first-page":"19726","DOI":"10.1016\/S0021-9258(19)36575-5","article-title":"Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation","volume":"268","author":"Parkkinen","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2013.11.007_bb0670","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1189\/jlb.1008585","article-title":"HMGB1 loves company","volume":"86","author":"Bianchi","year":"2009","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0675","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/sj.emboj.7601552","article-title":"A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin","volume":"26","author":"Orlova","year":"2007","journal-title":"EMBO J"},{"key":"10.1016\/j.thromres.2013.11.007_bb0680","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nri1594","article-title":"High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal","volume":"5","author":"Lotze","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0685","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/ni1457","article-title":"Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE","volume":"8","author":"Tian","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0690","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1517\/14728222.2011.575360","article-title":"HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation","volume":"15","author":"Nogueira-Machado","year":"2011","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.thromres.2013.11.007_bb0695","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1440-1711.2005.01314.x","article-title":"Evidence of Toll-like receptor molecules on human platelets","volume":"83","author":"Cognasse","year":"2005","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0700","doi-asserted-by":"crossref","first-page":"e41254","DOI":"10.1371\/journal.pone.0041254","article-title":"Platelet-derived Toll-like receptor 4 (Tlr-4) is sufficient to promote microvascular thrombosis in endotoxemia","volume":"7","author":"Stark","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2013.11.007_bb0705","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1074\/jbc.M306793200","article-title":"Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein","volume":"279","author":"Park","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2013.11.007_bb0710","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1189\/jlb.1209775","article-title":"Endogenous ligands of TLR2 and TLR4: agonists or assistants?","volume":"87","author":"Erridge","year":"2010","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0715","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/eurheartj\/ehq084","article-title":"Cellular actors, Toll-like receptors, and local cytokine profile in acute coronary syndromes","volume":"31","author":"Wyss","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.thromres.2013.11.007_bb0720","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/CIRCRESAHA.112.274241","article-title":"Engagement of platelet toll-like receptor 9 by novel endogenous ligands promotes platelet hyperreactivity and thrombosis","volume":"112","author":"Panigrahi","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.thromres.2013.11.007_bb0725","doi-asserted-by":"crossref","first-page":"e23132","DOI":"10.1371\/journal.pone.0023132","article-title":"TIRAP, an adaptor protein for TLR2\/4, transduces a signal from RAGE phosphorylated upon ligand binding","volume":"6","author":"Sakaguchi","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2013.11.007_bb0730","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0968-0004(96)10020-7","article-title":"The S100 family of EF-hand calcium-binding proteins: functions and pathology","volume":"21","author":"Schafer","year":"1996","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.thromres.2013.11.007_bb0735","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5551\/jat.9472","article-title":"Overexpression of receptor for advanced glycation end products induces monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cell line","volume":"19","author":"Hayakawa","year":"2012","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.thromres.2013.11.007_bb0740","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1161\/CIRCULATIONAHA.105.607333","article-title":"Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events","volume":"113","author":"Healy","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2013.11.007_bb0745","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1182\/blood-2004-02-0446","article-title":"MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes","volume":"104","author":"Vogl","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.11.007_bb0750","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ahj.2007.08.018","article-title":"Myeloid-related protein 8\/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial","volume":"155","author":"Morrow","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.thromres.2013.11.007_bb0755","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1189\/jlb.0607397","article-title":"S100A8\/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway","volume":"83","author":"Ghavami","year":"2008","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.thromres.2013.11.007_bb0760","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3132\/dvdr.2005.014","article-title":"Elevated release of sCD40L from platelets of diabetic patients by thrombin, glucose and advanced glycation end products","volume":"2","author":"Varo","year":"2005","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.thromres.2013.11.007_bb0765","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/01.RES.0000070111.98158.6C","article-title":"CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation","volume":"92","author":"Inwald","year":"2003","journal-title":"Circ Res"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384813005409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384813005409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T13:38:29Z","timestamp":1647092309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384813005409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":152,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0049384813005409"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2013.11.007","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of multiligand\/RAGE axis in platelet activation","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2013.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}